Liquid Biopsy Technologies Likely to Lead the Transformation of Cancer Profiling and Personalized Treatment Strategies
This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs), derived from bio-fluids such as blood and urine, for molecular analysis across research and healthcare settings. This study also evaluates the technology, clinical, patent, and application landscapes prevalent across liquid biopsy settings, while providing valuable insights across its global technological impact and future perspectives.
Our reports have been used by over 10K customers, including:
Cancer Diagnostics Market Research Report by Diagnostic Type (Biopsy and Cytology Test, Diagnostic Imaging Test, and Tumor Biomarkers), by Indication (Blood Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, and Kidney Cancer) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Liquid Biopsy Market Global Forecast by Cancer, Product, Sample, Circulating Biomarkers, Regions, Company Analysis A liquid biopsy is an emerging tool for the diagnosis of cancer disease nowadays. The liquid biopsy involves collecting samples and analysing tumours in the blood to diagnose cancer...
2020-2025 U.S. Hemostasis Market Database: Analyzers and Reagents, Shares and Segment Forecasts This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for major coagulation tests, as well as comprehensive lists of companies developing or marketing new technologies and products by...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing...
The Transformational Health team provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recent COVID-19 pandemic. Clinical...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global COVID-19 Diagnostics Market Report The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2021–2026. The RT-PCR testing segment constituted over 75% of the global COVID diagnostics...
2021 Italy Clinical Chemistry Market Assessment--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 55 Tests, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report is a study of the major business opportunities emerging in the clinical...
2020-2025 Middle East Hemostasis Market Database: 11Countries--Analyzers and Reagents, Shares and Segment Forecasts This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for major coagulation tests, as well as comprehensive lists of companies developing or marketing new technologies...
2020-2025 Italy Nucleic Acid Testing (NAT) Diagnostics Database: Market Shares and Forecasts for 100 Tests--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for infectious diseases, genetic diseases, cancer...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.